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Background: In this day and age, the
increased use of traditional communication
tools in the work environment such as
physical white boards, sticky notes, and
emails has become a burden on daily

    
   
are the main concerns. The need for reliable,
       
laboratory digital whiteboards is becoming
obvious, especially with the exponentially
increasing amount of molecular genetic
testing performed as part of daily clinical
practice. The use of commercial systems
is limited by high initial investment
      
implementation, and the lack of ability to be
customized.
Methods: We designed an internal laboratory
digital whiteboards system using Microsoft

planner platform (part of Microsoft (MS)
  !"#     
the platform through desktop computers
and secure mobile device applications. Two
main plans were created in MS planner: 1)
Molecular Diagnostic Team plan; and 2)
Heme Team plan. Each plan was divided
into buckets (e.g. pending cases, to do
list, clinical runs by date, current lab
issues, quality control, improvements, and
individual molecular pathologist’s assigned
cases progress). During the transition phase,
the implementation of the new system
was assessed and edited daily during the
laboratory daily huddle. Afterwards, to
evaluate the impact of digital whiteboards
# $  
assessment was performed using an online
survey questionnaire.
Results: An online survey was developed
and sent to the participants who used the
platform over a period of four months. In total,
58.3% responded by the time of collecting
the survey responses. All of the respondents
did use Microsoft planner for laboratory
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thought it was useful to switch to a digital
version of whiteboard, 100% prefered using
the platform over the conventional methods,
100% thought that the new platform improved
communication between lab personnel, 100%
thought that switching to the new platform
   +'*# #
that switching to the new platform improved
communication with pathologists and
trainees, 71% thought that switching to the
       -+*
thought that switching reduced the time spent
tracking cases.
Conclusion: Switching daily molecular
laboratory case annotation and tracking
system to a digital format may improve
staff communication, molecular laboratory
       
process. 
https://doi.org/10.32873/unmc.dc.gmerj.2.1.025
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Background: Cancer-related abdominal
pain is a common symptom associated with
upper intra-abdominal carcinoma, especially
in patients with advanced disease and it has
  #  #  
medical practitioners. Typically, cancer pain
can be managed by following the World
Health Organization 3-step analgesic ladder.
However, analgesic use of opioids, the
mainstay treatment for moderate-to-severe
cancer-related pain, may be ineffective in a
subset of cancer patients. Escalation of dosage
may be limited by opioid-induced side effects.
Thus, with 70-80% of advance-staged patients,
and up to 90% of those with bone metastases,
suffering from pain, ablative procedures
including neurolysis of the celiac/splanchnic
plexus should be sought to improve analgesic
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outcomes (1). Our objective was to review the
literature addressing the effect of neurolytic
celiac plexus block (NCPB) on the palliation
of pain emanating from advanced upper intraabdominal malignancies.
Methods: Electronic databases including
Medline/PubMed, EMBASE, and Cochrane
Library were searched. Only studies with a
high level of evidence were reviewed. These
included prospective randomized control
studies, systematic reviews and meta-analyses.
Further, references from included articles
were carefully reviewed for additional
relevant trials.

considered early for palliation of cancerrelated pain in advanced upper intraabdominal malignancies. This is especially
true for patients with intolerable opioidinduced adverse events and painful symptoms
resistant to oral analgesics. 
https://doi.org/10.32873/unmc.dc.gmerj.2.1.026

Results: A total of 13 prospective randomized
         6
analyses, and one Cochrane review article
were found to meet eligibility criteria.
Conclusion: Neurolysis of the celiac/
splanchnic plexus is an effective and
safe therapeutic modality that should be
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